bd revenu expect revenu vs street
greater expect neg fx ep beat expect ep vs street
infect control molecular highlight driver on-going dcb
weigh intervent busi manag reiter guidanc impli
midpoint street respect
trim forward ep number part delay concern lutonix btk dcb
result bd report cc revenu growth pjc report
street medic revenu growth cc
report street cc growth forecast life
scienc revenu growth cc report street
intervent revenu growth cc report
street adjust gross margin bpt yoy bpt due
fx bpt due mix street opex pjc
adjust ep street pjc favor tax rate offset
higher spend
busi updat manag note pma submiss paclitaxel drug
coat balloon lutonix knee indic suffici approv
may add addit data beyond month data origin
file assum lutonix btk approv chang current practic
dcb manag endors top line cc growth doubl digit ep
growth bd track de-lever target current plan
keep limit cash balanc sheet emphasi buy-back tuck
 addit comment reassess dividend assum bia
increas
guidanc manag reiter cc revenu growth impli
revenu street adjust ep cc growth guidanc
re-affirmed cc report adjust ep re-affirmed
street impli revenu
on-going ep street respect
stock good great quarter
acceler growth curv rel broad strength posit
indic fda delay suggest consensu like come
adjust forward ep expect lower target unch
competit new product execut foreign currenc acquisit integr
becton dickinson diversifi medic technolog compani
ep
debt total capit
actual may match report figur due restat associ divestitur complet end
ep includ sbc exclud item
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
becton dickinson compani
page
million except share per share data
updat
good sold
provis incom tax
good sold
good sold
current disclosur inform compani locat
